open access
C-reactive protein in COVID-19 patients
, 1, 2, 1
Affiliations- European School of Medicine, International European University, Kyiv, Ukraine
- Department of Trauma and Orthopedic Surgery, Ruda Slaska City Hospital, Ruda Slaska, Poland
open access
Abstract
Abstract
Keywords
COVID-19; C-reactive protein (CRP); inflammation; biomarker; pneumonia
About this articleTitle
C-reactive protein in COVID-19 patients
Journal
Disaster and Emergency Medicine Journal
Issue
Article type
Letter to the Editor
Pages
124-125
Published online
2023-03-14
Page views
1179
Article views/downloads
257
DOI
Bibliographic record
Disaster Emerg Med J 2023;8(2):124-125.
Keywords
COVID-19
C-reactive protein (CRP)
inflammation
biomarker
pneumonia
Authors
Yevhenii Symonets
Oleksandra Tuboltseva
Mahdi Al-Jeabory
Svitlana Doan
References (10)- Ansari-Moghaddam B, Ahmadi S, Matouri M, et al. Screening role of complete blood cell count indices and C reactive protein in patients who are symptomatic for COVID-19. Disaster and Emergency Medicine Journal. 2022; 7(3): 176–181.
- Ruetzler K, Szarpak L, Filipiak K, et al. The COVID-19 pandemic — a view of the current state of the problem. Disaster and Emergency Medicine Journal. 2020.
- Szarpak Ł, Nowak B, Kosior D, et al. Cytokines as predictors of COVID-19 severity: evidence from a meta-analysis. Pol Arch Intern Med. 2021; 131(1): 98–99.
- Fialek B, Yanvarova O, Pruc M, et al. Systematic review and meta-analysis of serum amyloid a prognostic value in patients with COVID-19. Disaster and Emergency Medicine Journal. 2022; 7(2): 107–113.
- Stringer D, Braude P, Myint PK, et al. COPE Study Collaborators. The role of C-reactive protein as a prognostic marker in COVID-19. Int J Epidemiol. 2021; 50(2): 420–429.
- Smilowitz NR, Kunichoff D, Garshick M, et al. C-reactive protein and clinical outcomes in patients with COVID-19. Eur Heart J. 2021; 42(23): 2270–2279.
- Su WL, Lu KC, Chan CY, et al. COVID-19 and the lungs: A review. J Infect Public Health. 2021; 14(11): 1708–1714.
- Ahnach M, Zbiri S, Nejjari S, et al. C-reactive protein as an early predictor of COVID-19 severity. J Med Biochem. 2020; 39(4): 500–507.
- Chi L, Wang S, Wang X, et al. Predictive value of C-reactive protein for disease severity and survival in COVID-19 patients: a systematic review and meta-analysis. Clin Exp Med. 2022 [Epub ahead of print]: 1–8.
- O'Shaughnessy J, DeMichele A, Ma CX, et al. A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation. Breast Cancer Res Treat. 2018; 170(3): 547–557.